$CORZ

DUCHENE TODD M sold $223K of CORZ

DUCHENE TODD M (See remarks) sold 10,000 shares of Core Scientific, Inc./tx (CORZ) at $22.30 ($0.22M total) on 2026-07-20 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · DUCHENE TODD M
Published Jul 22, 2026, 8:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 22, 2026, 8:18 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CORZ
Neutral
high confidence
Mentioned
$CORZ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CORZNeutralLow
01

Why it matters

The disclosure updates the record of insider activity but does not introduce new guidance, contracts, litigation, or operational changes.

02

Market read

Traders may note insider selling, but the 10b5-1 structure reduces the likelihood of a fundamental catalyst.

03

What to watch

Insider sales can be mechanically scheduled; without accompanying buys or new disclosures, the signal-to-noise for trading is low.

Relevance 3/10Novelty 3/10Timing: new SEC Form 4 filed 2026-07-22 for a 2026-07-20 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Core Scientific, Inc.

Company-level read

Ticker impact

$CORZNeutralHigh confidence
Context

SEC Form 4 shows officer DUCHENE TODD M sold 10,000 CORZ shares on 2026-07-20 under a 10b5-1 plan for about $223K.

Expected impact

Likely minimal, with any effect confined to short-term sentiment rather than a fundamental repricing.

Evidence & confidence

The filing is an insider sale (not a purchase), explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company-specific operational or financial information.

Market effects

No sector-level read-across; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The sale may reflect diversification or scheduled liquidity needs rather than bearish expectations because it is executed under a 10b5-1 plan.

Key entities

  • Core Scientific, Inc.

    Subject of the SEC Form 4 insider transaction disclosure (CORZ).

  • DUCHENE TODD M

    Officer who sold 10,000 shares on 2026-07-20 under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CRWVMed

CoreWeave, AI landlord stocks sink to lowest levels in more than a year as the price of insuring CoreWeave's debt doubles

Neocloud stocks, including CoreWeave (CRWV), IREN, Core Scientific (CORZ), and Cipher Mining (CIFR), have fallen over 40% since July. CoreWeave's credit default swap costs have doubled, signaling increased default risk. Microsoft (MSFT) has gained nearly as much. Nebius (NBIS) is an exception, performing better due to lower debt. Elon Musk noted lenders are restricting funding for AI data center-dependent companies.

$BTC-USDMed

AI Pivot Fails to Slow Bitcoin Mining Competition as Hashrate Surges

Bitcoin's network hashrate hit a seven-month high of 1 zettahash per second, despite large miners shifting to AI. Mining difficulty rose 5.92% in October, with another 5.16% increase expected. Public miners' hashrate fell 23% while AI revenue rose 52% in Q2 2026, displacing about $1.5 billion in equipment. Companies like Core Scientific and IREN reduced Bitcoin production, while MARA and Riot absorbed displaced network share.

$APLDMed

Applied Digital Sinks 4% as Rotation Out of Debt-Funded AI Builders Extends; TeraWulf Dips 3%, Core Scientific Retreats 2%

Applied Digital (APLD) shares fell 4% to $19.59, extending a downturn in leveraged AI data center developers. TeraWulf (WULF) and Core Scientific (CORZ) also declined. JPMorgan cut APLD's bond rating to Neutral, citing debt concerns. APLD reported strong Q1 revenue growth but carries significant debt. Management maintains confidence in its balance sheet and funding plans.

$CORZHigh

KBW keeps Core Scientific at outperform, says AMD’s 1.9 GW reservation is overlooked

KBW reiterated its Outperform rating and $28 price target on Core Scientific (CORZ), citing overlooked 1.9 GW of AMD reservation capacity. The firm values existing leases at $15.54 per share, with a blended NOI/EV yield of 8.3%. KBW attended Core Scientific's investor day and noted AMD's option for additional capacity. CORZ closed at $15.43 on Tuesday, implying 81.5% upside to the target.